Home > News
News
15th February 2021 - WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, for these vaccines to be rolled out globally through COVAX Facility. The vaccines are produced by SKBio (Republic of Korea) and the Serum Institute of India...
Brasilia 17th January 2021 – The Brazilian Regulatory Agency ANVISA authorized the emergency use of vaccines from Oxford-AstraZeneca and China’s Sinovac, doses of which will be distributed by local public partners, Fiocruz and Butantan, in all 27 states. Brazil has...
Partners:
